Joe Shulman was promoted to Chief Technical Officer in 2022. He had joined Rhythm as our Senior Vice President, Technical Operations in July 2020. Joe brings more than 20 years of industry experience and is responsible for chemistry, manufacturing, and controls (CMC), clinical and commercial supply chains, and cGMP quality assurance and quality control. Prior to joining Rhythm, Joe served as Senior Vice President of Technical Operations at Ra Pharmaceuticals, acquired by UCB in 2020, where he oversaw all aspects of CMC development, pre-commercialization supply chain planning and strategy as a member of the executive leadership team. Before that, he was senior vice president of global technical operations at Novelion Therapeutics, where he had responsibility for CMC, quality assurance, program management, patient/hub services, and global patient supply of Juxtapid® and Myalept®, two globally marketed products for rare metabolic diseases.  Earlier in his career, Joe held roles of increasing responsibility at biotechnology companies in the areas of CMC, technical operations, and program and alliance management. He holds an M.B.A. from Boston University and earned a B.S. in chemical engineering from Miami University.